Skip to content
Home
About us
The technology
Current Threats
Our team
Contact us
Home
About us
The technology
Current Threats
Our team
Contact us
Envelope
Linkedin
Youtube
Why Our AI Engine Matters
End-To-End Process
From AI design to targeted RNA degradation
Scientific Validation
97.1% Efficiency Reducing Cell Mortality
5 Human Cell Types
p = 0.0007
No Significant Toxicity Observed
Key Advantages Of The Platform
Initial Program-Antiviral pipeline
Significant Milestones
Market Opportunity
Viritis Main Team
Built by Experts in AI, Therapeutics & Drug Development
Dr. Amit Philosoph CTO
Amit Turman CEO
Aharon Wistoch Chairman & CFO
Dr. Sharon Navon Advisor
Dr. Emiliano Cohen Head of AI
Dr Ayana Dagan Wiener AI Spacilaist
Be a part of the future of therapeutics
Join Us
Click here
Click here
English
English
Deutsch
Español
Français
Italiano
Polski
Svenska
Suomi
Português
Română
Slovenščina
Slovenčina
Nederlands
Dansk
Ελληνικά
Čeština
Magyar
Lietuvių
Latviešu
Eesti
Hrvatski
Gaeilge
Български
Norsk
Türkçe
Bahasa Indonesia
Português (Brasil)
日本語
한국어
简体中文
العربية
Русский
हिन्दी
Українська
Srpski
English (UK)
ایران
ישראל
Македонија
ประเทศไทย
Việt Nam
Accessibility Adjustments
Powered by
OneTap
Hide Toolbar
Back
How long do you want to hide the toolbar?
Hide Toolbar Duration
Only for this session
24 hours
A Week
Not Now
Hide Toolbar
Select your accessibility profile
Vision Impaired Mode
Enhances website's visuals
Seizure Safe Profile
Clear flashes & reduces color
ADHD Friendly Mode
Focused browsing, distraction-free
Blindness Mode
Reduces distractions, improves focus
Epilepsy Safe Mode
Dims colors and stops blinking
Content Modules
Font Size
+
Default
-
Readable Font
Line Height
+
Default
-
Cursor
Letter Spacing
Align Text
Font Weight
Color Modules
Light Contrast
High Contrast
Monochrome
Orientation Modules
Reading Line
Reading Mask
Hide Images
Highlight Content
Stop Animations
Highlight Links
Reset Settings